Trial · NCT01081795
Adverse events66
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 66
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Nasopharyngitis | Infections and infestations | Topiramate (JNS019) 50 mg | 45 | 130 | |
| other | Nasopharyngitis | Infections and infestations | Topiramate 100 mg | 39 | 130 | |
| other | Nasopharyngitis | Infections and infestations | Placebo | 37 | 127 | |
| other | Decreased appetite | Metabolism and nutrition disorders | Topiramate (JNS019) 50 mg | 8 | 130 | |
| other | Decreased appetite | Metabolism and nutrition disorders | Topiramate 100 mg | 11 | 130 | |
| other | Decreased appetite | Metabolism and nutrition disorders | Placebo | 3 | 127 | |
| other | Paraesthesia | Nervous system disorders | Topiramate (JNS019) 50 mg | 38 | 130 | |
| other | Paraesthesia | Nervous system disorders | Topiramate 100 mg | 50 | 130 | |
| other | Paraesthesia | Nervous system disorders | Placebo | 4 | 127 | |
| other | Dysaesthesia | Nervous system disorders | Topiramate (JNS019) 50 mg | 35 | 130 | |
| other | Dysaesthesia | Nervous system disorders | Topiramate 100 mg | 26 | 130 | |
| other | Dysaesthesia | Nervous system disorders | Placebo | 7 | 127 | |
| other | Somnolence | Nervous system disorders | Topiramate (JNS019) 50 mg | 21 | 130 | |
| other | Somnolence | Nervous system disorders | Topiramate 100 mg | 16 | 130 | |
| other | Somnolence | Nervous system disorders | Placebo | 15 | 127 | |
| other | Disturbance in attention | Nervous system disorders | Topiramate (JNS019) 50 mg | 7 | 130 | |
| other | Disturbance in attention | Nervous system disorders | Topiramate 100 mg | 4 | 130 | |
| other | Disturbance in attention | Nervous system disorders | Placebo | 2 | 127 | |
| other | Upper respiratory tract inflammation | Respiratory, thoracic and mediastinal disorders | Topiramate (JNS019) 50 mg | 13 | 130 | |
| other | Upper respiratory tract inflammation | Respiratory, thoracic and mediastinal disorders | Topiramate 100 mg | 16 | 130 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT01081795/events